View of Does a REV-ERB Synthetic Agonist Hold Utility as a Protective Agent Against Chemotherapy-Induced Heart Failure?

Return to Article Details Does a REV-ERB Synthetic Agonist Hold Utility as a Protective Agent Against Chemotherapy-Induced Heart Failure? Download Download PDF